Latest filing published 04 Mar 2014 for MEDICINES CO /DE, €36k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Paul Michael Antinori: trading record in brief
Paul Michael Antinori is a declared insider of Medicines Co /DE, with filings sourced from SEC (Form 4). The record holds 89 filings, for trades running from 27 February 2006 to 3 March 2014.
Market trades split into 1 purchase (€12k) and 42 sales (€9.6M). Taken together, the sales exceed the purchases by €9.6M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 14 share grants and 21 option exercises. In 2014 alone, the filings show no purchases and 4 sales.
The latest filing, published on 4 March 2014, reports a share grant of €36k in Medicines Co /DE. The most recent open-market purchase was published on 6 August 2007, 7,034 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Paul Michael Antinori
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,641 shares@ US$30.49Common StockSEC:0001179110-14-004370:0
- 3,682 shares0Common StockSEC:0001179110-14-004370:1
- 1,086 shares@ US$30.08Common StockSEC:0001179110-14-004370:2
- 12 shares@ US$29.99Common StockSEC:0001179110-14-004370:3
- 350 shares@ US$30.03Common StockSEC:0001179110-14-003351:0
- 542 shares@ US$29.73Common StockSEC:0001179110-14-003351:1
- 10,500 shares@ US$7.31Common StockSEC:0001179110-14-001313:0
- 10,500 shares@ US$38.00Common StockSEC:0001179110-14-001313:1
- 20,000 shares@ US$14.82Common StockSEC:0001179110-14-001313:2
- 20,000 shares@ US$38.09Common StockSEC:0001179110-14-001313:3
- 7,000 shares@ US$17.45Common StockSEC:0001179110-14-001313:4
- 7,000 shares@ US$37.82Common StockSEC:0001179110-14-001313:5
- 383 shares@ US$38.05Common StockSEC:0001179110-14-001313:6
- 10,000 shares@ US$37.01Common StockSEC:0001179110-13-018093:0
- 9,600 shares@ US$36.91Common StockSEC:0001179110-13-018093:1
- 894 shares@ US$33.16Common StockSEC:0001179110-13-014869:0
- 23,500 shares@ US$28.02Commmon StockSEC:0001179110-13-014302:0
- 50,000 shares@ US$28.60Common StockSEC:0001179110-13-014302:1
- 73,500 shares@ US$34.50Common StockSEC:0001179110-13-014302:2
- 36,000 shares@ US$23.77Common StockSEC:0001179110-13-011671:0
- 36,000 shares@ US$33.00Common StockSEC:0001179110-13-011671:1
- 50,690 shares@ US$19.36Common StockSEC:0001179110-13-010367:0
- 50,690 shares@ US$33.29Common StockSEC:0001179110-13-010367:1
- 9,283 shares@ US$12.95Common StockSEC:0001179110-13-010367:2
- 9,283 shares@ US$33.29Common StockSEC:0001179110-13-010367:3
25 of 88 declarations